FCCC LOGO Faculty Publications
Ettinger DS , Aisner DL , Wood DE , Akerley W , Bauman J , Chang JY , Chirieac LR , D'Amico TA , Dilling TJ , Dobelbower M , Govindan R , Gubens MA , Hennon M , Horn L , Lackner RP , Lanuti M , Leal TA , Lilenbaum R , Lin J , Loo BW Jr , Martins R , Otterson GA , Patel SP , Reckamp K , Riely GJ , Schild SE , Shapiro TA , Stevenson J , Swanson SJ , Tauer K , Yang SC , Gregory K , Hughes M
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018
J Natl Compr Canc Netw. 2018 Jul;16(7) :807-821
PMID: 30006423   
Back to previous list
Abstract
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.
Notes
1540-1413 Ettinger, David S Aisner, Dara L Wood, Douglas E Akerley, Wallace Bauman, Jessica Chang, Joe Y Chirieac, Lucian R D'Amico, Thomas A Dilling, Thomas J Dobelbower, Michael Govindan, Ramaswamy Gubens, Matthew A Hennon, Mark Horn, Leora Lackner, Rudy P Lanuti, Michael Leal, Ticiana A Lilenbaum, Rogerio Lin, Jules Loo, Billy W Jr Martins, Renato Otterson, Gregory A Patel, Sandip P Reckamp, Karen Riely, Gregory J Schild, Steven E Shapiro, Theresa A Stevenson, James Swanson, Scott J Tauer, Kurt Yang, Stephen C Gregory, Kristina Hughes, Miranda Journal Article United States J Natl Compr Canc Netw. 2018 Jul;16(7):807-821. doi: 10.6004/jnccn.2018.0062.